Skip to main content
. 2021 Jan 21;6(4):3037–3045. doi: 10.1021/acsomega.0c05377

Table 5. Top 10 New Drug–Target Interactions on the GPCR Data Set.

GPCR rank pair & name
DrugBank D01699: darifenacin (DrugBank ID DB00496), Hsa:1128: muscarinic acetylcholine receptor M1 (UniProtKB P11229)
D00465: oxybutynin (DrugBank ID DB01062), Hsa:57105: cysteinyl leukotriene receptor 2 (UniProtKB Q9NS75)
D00465: oxybutynin (DrugBank ID DB01062), Hsa:10800: cysteinyl leukotriene receptor 1 (UniProtKB Q9Y271)
D00645: bretylium (DrugBank ID DB01158), Hsa:1128: muscarinic acetylcholine receptor M1 (UniProtKB P11229)
Kegg D00765: rocuronium (DrugBank ID DB00728), Hsa:1128: muscarinic acetylcholine receptor M1 (UniProtKB P11229)
DrugBank D01699: darifenacin (DrugBank ID DB00496), Hsa:1129: muscarinic acetylcholine receptor M2 (UniProtKB P08172)
D00465: oxybutynin (DrugBank ID DB01062), Hsa:134: adenosine receptor A1 (UniProtKB P30542)
D00645: bretylium (DrugBank ID DB01158), Hsa:1129: muscarinic acetylcholine receptor M2 (UniProtKB P08172)
D00465: oxybutynin (DrugBank ID DB01062), Hsa:135: adenosine receptor A2a (UniProtKB P29274)
DrugBank D00765: rocuronium (DrugBank ID DB00728), Hsa:1129: muscarinic acetylcholine receptor M2 (UniProtKB P08172)